Search
for

    Glossary KX826

    KX826 is a novel topical treatment developed for androgenetic alopecia, commonly known as male or female pattern hair loss. It functions as a dual-action agent, targeting both the androgen receptors and promoting hair follicle growth, which distinguishes it from traditional treatments like minoxidil and finasteride. Its relevance lies in its potential to offer a more effective solution for hair regrowth by addressing the hormonal factors contributing to hair loss while also stimulating hair follicle activity. Clinical trials have shown promising results, making KX826 a noteworthy option in the evolving landscape of hair loss therapies.

    Related Terms

    Sort by

    Research 11

    1. 587 Efficacy and Safety of topical KX-826 in Male Subjects with Androgenetic Alopecia:A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study Journal of Investigative Dermatology · 2022
    2. Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia Frontiers in Pharmacology · 2026
    3. A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies IP Indian Journal of Clinical and Experimental Dermatology · 2025
    4. Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique HAL (Le Centre pour la Communication Scientifique Directe) · 2025
    5. Androgenetic Alopecia: Therapy Update Drugs · 2023
    6. The 100 most cited articles in androgenetic alopecia: A bibliometric analysis Medicine · 2025
    7. Mechanism exploration of the combined use of minoxidil with natural compounds ginsenoside Rg3 and glycyrrhizic acid for enhancing androgenic alopecia therapy Journal of Drug Delivery Science and Technology · 2025
    8. Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches Premier journal of science. · 2026
    9. Focused Review on Metal Nanoparticles in Hair Regeneration and Alopecia: Insights into Mechanisms, Assessment Techniques, Toxicity, Regulatory and Intellectual Property Perspectives Journal of Cluster Science · 2025
    10. Recent Advances in Drug Development for Hair Loss International Journal of Molecular Sciences · 2025
    11. Comparison of three different lactic acid bacteria-fermented proteins on RAW 264.7 osteoclast and MC3T3-E1 osteoblast differentiation Scientific reports · 2023